Krystal Biotech Reports First Quarter 2020 Financial Results and Provides Update on Operational …,

B-VEC Phase 3 pivotal study anticipated to start in 1H 2020 … “In 2020, we anticipate treating patients across three different clinical trials for skin …, B-VEC Phase 3 pivotal study anticipated to start in 1H 2020 … “In 2020, we anticipate treating patients across three different clinical trials for skin …, Read More

Scroll to Top